Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports on Hemophilia and Primary Biliary Cholangitis

BOSTON, Nov. 02, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape reports on Primary Biliary Cholangitis (PBC) and Hemophilia. The Novotech research analyst team offers these expert reports monthly at no cost. These reports provide up-to-date information on global clinical trial activity, shedding light [...]